Insider filing · EXEL
Amy C. Peterson sold $3.3M of Exelixis (EXEL)
Executed May 16 2025, disclosed May 16 2025, the same day.
Value, as filed
$3.3M
72,776 sh × $45.47
Executed
May 16 2025
the trade date, as filed
Disclosed
May 16 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AP
Amy C. Peterson
EVP Prod Dev & Med Aff & CMO
profile →
Amy C. Peterson (EVP Prod Dev & Med Aff & CMO) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $3.3M of EXEL (72,776 sh × $45.47, as filed), executed May 16 2025.
The name
EXEL
Exelixis, Inc.
EXEL · Healthcare · 48 filings in 24 months
ticker →
Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→